Clene Inc.
corporate_fare Company Profile
Clene Inc. (NASDAQ:CLNN) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 42 items for CLNN at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Clene Announces Strong Biomarker Data for ALS Drug CNM-Au8, Secures Key FDA Meeting for Accelerated Approval Pathway
- Clene Inc. Secures $5.67M in Equity and Warrant Offering at Premium to Market, Addressing Going Concern
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$200K
Net Income
-$26.17M
Op. Cash Flow
-$18.55M
Free Cash Flow
-$18.59M
Gross Profit
$157K
Operating Income
-$23.08M
Cash & Equivalents
$5.19M
Total Debt
$17.79M
Debt / Equity
-1.01×
Net Margin
-130.87×
Shares Outstanding
10.85M sh
Source: 10-K · filed 2026-03-17 · accession 0001437749-26-008502
show_chartPrice Chart
Loading chart...